Universität zu Köln

Malter, Michael P. (2020). Epilepsy with antibodies against glutamate decarboxylase (GAD). Z. Epileptol., 33 (4). S. 303 - 306. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 1610-0646

Full text not available from this repository.

Abstract

Epilepsy associated with antibodies against glutamate decarboxylase (GAD) occurs as pure epilepsy or in the context of autoimmune neurological syndromes. Antibodies against GAD are not directly pathogenic but serve as biomarkers for an underlying autoimmune disease. Prognostically, a chronic course with poor response to immunotherapy or other anticonvulsive treatment often develops.

Item Type:	Journal Article
Creators:	Creators Email ORCID ORCID Put Code Malter, Michael P. UNSPECIFIED UNSPECIFIED UNSPECIFIED
URN:	urn:nbn:de:hbz:38-319402
DOI:	10.1007/s10309-020-00363-3
Journal or Publication Title:	Z. Epileptol.
Volume:	33
Number:	4
Page Range:	S. 303 - 306
Date:	2020
Publisher:	SPRINGER HEIDELBERG
Place of Publication:	HEIDELBERG
ISSN:	1610-0646
Language:	German
Faculty:	Unspecified
Divisions:	Unspecified
Subjects:	no entry
Uncontrolled Keywords:	Keywords Language TEMPORAL-LOBE EPILEPSY; ACID-DECARBOXYLASE; IMMUNOTHERAPY; THERAPY; CLUES Multiple languages Clinical Neurology Multiple languages
URI:	http://kups.ub.uni-koeln.de/id/eprint/31940